What is Bergad?
Bergad Specialty Foams operates as a critical player in the engineered materials landscape, providing high-performance polyurethane, acoustic, and biodegradable foam solutions. By leveraging over three decades of technical expertise, the company serves a diverse array of high-stakes industries, including medical device manufacturing, military defense, transportation, and consumer electronics. Their commitment to quality is evidenced by ISO 9001:2015 certification, which facilitates their role as a preferred partner for complex prototyping and custom formulation. Through a vertically integrated approach that spans research and development to final manufacturing, Bergad ensures that its material science innovations meet the rigorous performance requirements of modern industrial applications.
How much funding has Bergad raised?
Bergad has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Bergad
PPP
Public-Private Partnership
What's next for Bergad?
The infusion of capital positions Bergad to accelerate its research and development initiatives, potentially expanding its portfolio of biodegradable and high-performance acoustic materials. As the company transitions through this late-stage growth phase, the focus will likely shift toward optimizing manufacturing throughput and deepening its penetration into global supply chains. By enhancing its custom formulation capabilities, Bergad is well-positioned to capture additional market share in the medical and defense sectors, where demand for specialized, durable foam components remains resilient. Future strategic efforts will likely prioritize operational efficiency and the scaling of production capacity to meet the evolving needs of its diverse industrial client base.
See full Bergad company page
